Acquisitions, donations & more — 4 GI company key notes

Here are four updates on GI companies from the past week:

Takeda, Sweden-based Karolinska Institutet and The Structural Genomics Consortium entered into a precompetitive and proprietary collaboration agreement to research and test potential intervention points for inflammatory bowel disease.

Takeda Pharmaceuticals U.S.A. donated $100,000 to local and regional nonprofits as part of its annual Takeda Cares Day.

EnteroMedics acquired ReShape Medical and its ReShape Dual Weight Loss Balloon, a minimally invasive intragastric balloon system.

TransMed7, a medical device company, appointed Michael Demeure, MD, chair of its endocrine and gastrointestinal health team.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast